Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years.

Tellini R, Antonelli A, Tardanico R, Fisogni S, Veccia A, Furlan MC, Carobbio F, Cozzoli A, Zanotelli T, Simeone C.

Clin Genitourin Cancer. 2018 Aug 23. pii: S1558-7673(18)30398-7. doi: 10.1016/j.clgc.2018.08.004. [Epub ahead of print]

PMID:
30266249
2.

Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal Cancer.

Shelar S, Shim EH, Brinkley GJ, Kundu A, Carobbio F, Poston T, Tan J, Parekh V, Benson D, Crossman DK, Buckhaults PJ, Rakheja D, Kirkman R, Sato Y, Ogawa S, Dutta S, Velu SE, Emberley E, Pan A, Chen J, Huang T, Absher D, Becker A, Kunick C, Sudarshan S.

Clin Cancer Res. 2018 Aug 14. doi: 10.1158/1078-0432.CCR-18-1727. [Epub ahead of print]

PMID:
30108105
3.

Features of Ipsilateral Renal Recurrences After Partial Nephrectomy: A Proposal of a Pathogenetic Classification.

Antonelli A, Furlan M, Tardanico R, Fisogni S, Sodano M, Carobbio F, Belotti S, Cozzoli A, Zanotelli T, Simeone C.

Clin Genitourin Cancer. 2017 Oct;15(5):540-547. doi: 10.1016/j.clgc.2017.04.028. Epub 2017 Apr 26.

PMID:
28533051
4.

External histopathological validation of the surface-intermediate-base margin score.

Antonelli A, Furlan M, Sodano M, Carobbio F, Tardanico R, Fisogni S, Simeone C.

Urol Oncol. 2017 May;35(5):215-220. doi: 10.1016/j.urolonc.2016.12.011. Epub 2017 Jan 18.

PMID:
28109581
5.

Positive surgical margins and early oncological outcomes of robotic vs open radical prostatectomy at a medium case-load institution.

Antonelli A, Sodano M, Peroni A, Mittino I, Palumbo C, Furlan M, Carobbio F, Tardanico R, Fisogni S, Simeone C.

Minerva Urol Nefrol. 2017 Feb;69(1):63-68. doi: 10.23736/S0393-2249.16.02518-2. Epub 2016 Mar 9.

PMID:
28009146

Supplemental Content

Loading ...
Support Center